Literature DB >> 23837928

Antibacterial activity of head-to-head bis-benzimidazoles.

Joao B Moreira1, John Mann, Stephen Neidle, Timothy D McHugh, Peter W Taylor.   

Abstract

Symmetric bis-benzimidazole (BBZ) conjugates were profiled for activity against a range of Gram-positive and Gram-negative bacteria. para-Substituted ethoxy, amino and methoxy derivatives displayed potent bacteriostatic activity against meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, streptococci and Listeria monocytogenes. Moderate to good activity was also found against mycobacteria; two compounds were strongly active against logarithmic phase and hypoxia-induced latent Mycobacterium tuberculosis. No compound displayed significant activity towards Gram-negative bacteria. Only high concentrations of antibacterial BBZs showed cytotoxic effects towards fibroblasts, and the most active compound was well tolerated by zebrafish embryos.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Antibacterial bis-benzimidazoles; Gram-positive pathogens; Mycobacterium tuberculosis; Staphylococcus aureus

Mesh:

Substances:

Year:  2013        PMID: 23837928     DOI: 10.1016/j.ijantimicag.2013.04.033

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

1.  Anti-biofilm studies of synthetic imidazolium salts on dental biofilm in vitro.

Authors:  Ting Pan; Feng-Shou Liu; Huancai Lin; Yan Zhou
Journal:  J Oral Microbiol       Date:  2022-05-17       Impact factor: 5.833

2.  Design, synthesis and therapeutic potential of 3-(2-(1H-benzo[d]imidazol-2-ylthio)acetamido)-N-(substituted phenyl)benzamide analogues.

Authors:  Sumit Tahlan; Kalavathy Ramasamy; Siong Meng Lim; Syed Adnan Ali Shah; Vasudevan Mani; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-12-19       Impact factor: 4.215

Review 3.  The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: a story of an effective academic-industrial partnership.

Authors:  John Mann; Peter W Taylor; Colin R Dorgan; Peter D Johnson; Francis X Wilson; Richard Vickers; Aaron G Dale; Stephen Neidle
Journal:  Medchemcomm       Date:  2015-07-20       Impact factor: 3.597

Review 4.  Antimicrobial potential of 1H-benzo[d]imidazole scaffold: a review.

Authors:  Sumit Tahlan; Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  BMC Chem       Date:  2019-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.